DSV has expanded its Air ThermoDirect solution with the launch of a new direct air freight connection between Luxembourg and Indianapolis, aimed at strengthening temperature-controlled pharmaceutical supply chains. The new route will operate through Indianapolis International Airport, one of the fastest-growing life sciences and healthcare logistics hubs in the United States, enhancing cold-chain connectivity between major pharmaceutical manufacturing and distribution centres. According to DSV, the service is designed to reduce the time pharmaceutical products spend in uncontrolled environments while eliminating the complexity associated with active containers. The company said the approach will help customers improve product integrity while lowering costs, emissions and operational risks. The Luxembourg–Indianapolis connection links two important pharmaceutical logistics gateways and is intended to provide a more predictable and scalable cold chain solution while supporting sustainability objectives through optimized handling processes and thermal management technologies. Kenneth Källström, Executive Vice President and Global Head of Healthcare at DSV, said, “The DSV Indianapolis operations will play a pivotal role in the global Air ThermoDirect healthcare network, enhancing end-to-end visibility and control across pharma manufacturing regions in the US, Europe, the Americas, and APAC.” He added, “By strengthening these critical supply-chain connections, this hub will help ensure that life-saving therapies move with greater speed, reliability, and integrity — ultimately delivering better outcomes for patients worldwide.” Stephanie Penarete, Vice President Air Product Americas at DSV, said, “Indy Wings reflects our strategy to bring the critical points of the supply chain under full accountability, ensuring reliability, integrity and performance where it matters most.” She added that the new connection will help link key pharmaceu